Can a pregnant woman receive a tetanus toxoid (Td) injection after 13 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, tetanus injection can and should be given after 13 weeks in pregnancy

Tetanus toxoid-containing vaccines (Td or Tdap) are safe and recommended throughout pregnancy, including after 13 weeks gestation, with the optimal timing being between 27-36 weeks. 1, 2

Recommended Timing and Approach

Standard Recommendation

  • Tdap (tetanus, diphtheria, and acellular pertussis) should be administered during EVERY pregnancy between 27-36 weeks gestation 1, 2
  • The vaccine can be safely given at any time during pregnancy if needed 1, 3, 4
  • At 13 weeks, you are well within the safe window for administration

Why 27-36 Weeks is Optimal (But Not Mandatory)

The third trimester timing maximizes:

  • Maternal antibody production (requires minimum 2 weeks post-vaccination) 1
  • Passive antibody transfer to the fetus (active transport begins substantially after 30 weeks) 1
  • Protection for the newborn during the vulnerable first 2 months of life before their own vaccination series begins 3, 5

However, earlier administration (including at 13 weeks) is appropriate and effective when:

  • Wound management requires tetanus prophylaxis 1
  • There are pertussis outbreaks 3
  • The patient may not return for later prenatal visits
  • Any other clinical indication exists 6, 5

Safety Profile

Maternal and Fetal Safety

  • No evidence of adverse fetal effects from tetanus toxoid-containing vaccines in pregnancy 3, 4
  • Large studies on tetanus toxoid use during pregnancy have not reported clinically significant severe adverse events 1
  • Animal studies show no evidence of fetal harm 7
  • A study of 7,152 pregnant women receiving Tdap showed no increase in stillbirths, major malformations, or neonatal complications 8

Common Side Effects

  • Local reactions (pain, redness, swelling at injection site) are common but mild 7
  • Systemic reactions (fever, malaise, headache) occur but are generally well-tolerated 9

Special Considerations at 13 Weeks

If administering Tdap at 13 weeks:

  • This provides immediate protection against tetanus
  • For pertussis protection of the newborn, evidence from Argentina shows effectiveness even when given during the second trimester (≥20 weeks) 5
  • Canadian guidelines support administration from 13 weeks up to delivery 6
  • The patient should still receive Tdap in every subsequent pregnancy 1, 4

Clinical Pitfalls to Avoid

  1. Do not withhold tetanus vaccination due to pregnancy - this is a common misconception
  2. Do not give more frequently than every 10 years outside of pregnancy to avoid Arthus-type hypersensitivity reactions 7
  3. Ensure proper documentation to prevent over-immunization 10
  4. If the patient has unknown vaccination status, complete the primary series (3 doses at 0,4 weeks, and 6-12 months), with one dose being Tdap preferably at 27-36 weeks 1

Bottom Line Algorithm

At 13 weeks gestation:

  • ✓ Safe to administer tetanus toxoid (Td or Tdap)
  • ✓ Provides immediate maternal protection
  • ✓ Consider repeating Tdap at 27-36 weeks for optimal infant protection if given as Td now
  • ✓ If giving Tdap now for wound management or other indication, this dose counts toward pregnancy protection, though some guidelines support re-dosing at optimal timing for maximal infant benefit

References

Guideline

maternal vaccination: a review of current evidence and recommendations.

American Journal of Obstetrics and Gynecology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.